Uzan, SerhatBarış Cebe, DenizÇolak, MehmetAydın, HalukHoşgören, Halil2021-04-092021-04-092016-11-24Uzan, S., Barış Cebe, D., Çolak, M., Aydın, H., Hoşgören, H. (2016). Organogels as novel carriers for dermal and topical drug delivery vehicles. Tetrahedron, 72 (47), pp. 7517-7525. https://doi.org/10.1016/j.tet.2016.10.0090040-4020https://doi.org/10.1016/j.tet.2016.10.009https://hdl.handle.net/20.500.12402/2823Aminoalcohol based bis-(aminoalcohol)oxalamides (BAOAs) (1,6-amino alcohol=leucinol, isoleucinol, valinol, phenylglycinol, phenylalaninol and 2-amino-1-butanol) have been explored to develop drug depot systems and illustrated as a novel dermal and topical drug delivery vehicle for non-steroidal anti-inflammatory drug molecules. FAE's (Fatty acid ethyl and isopropyl esters) with different chain lengths, ethyl laurate, ethyl myristate, ethyl palmitate, isopropyl laurate, isopropyl myristate, isopropyl palmitate, have been chosen as they are biocompatible organic fluids used typically in cosmetic industry. Ibuprofen (Ib), acting as a model drug, was entrapped in the supramolecular organogels. The release behavior of Ib molecules in the supramolecular organogels was investigated by using UV–vis spectroscopy. The influence of the organogelator and drug concentration, pH values of the accepting media, and nature of solvent (different FAE's) on the release behavior of Ib was investigated under static conditions. The results indicated that the release rate of Ib from the supramolecular organogels was effectively retarded with an increase of the organogelator concentration. Also, the release rates of Ib increased on increasing the Ib content. Furthermore, the release behavior of Ib was found to be different at various pH values in buffers as accepting media. The study of the release kinetics indicated that the release behavior of Ib was in accord with the Higuchi equation and the diffusion-controlled mechanism involved in the Fickian model. These observations indicate that bis-(aminoalcohol)oxalamides gels may act as delivery vehicles for non-steroidal anti-inflammatory drug molecules and also show that the release profiles for such systems can be fine-tuned by the correct choice of gelator-FAE combination.eninfo:eu-repo/semantics/openAccessAttribution-NonCommercial-ShareAlike 3.0 United StatesGelsLMWOGs (Low Molecular Weight Organojelators)Controlled ReleaseDrug Delivery SystemsFormulationFormulation VehicleFtırArticle724775177525Q2Q2